Statistically, your risk for cancer goes up from the very first sip of alcohol. However, what’s lost in this messaging is how ...

Novo Nordisk’s Ozempic (semaglutide) has been approved by the US Food and Drug Administration (FDA) to reduce the risk of ...

Euro US Dollar, Compagnie Financiere Richemont SA, Burberry Group PLC, ASML Holding NV. Read Jakub Rochlitz's latest article on Investing.com ...

Wall Street investors, spurred on by Trump's pro-business agenda, could be ignoring real risks posed by the president.

Novo Nordisk has reported topline outcomes from a Phase Ib/IIa trial of amycretin designed for treating obese or overweight ...

Novo Nordisk announced positive trial results for its next-generation obesity drug, leading to a 7.13% surge in its share ...

Alphabet also remains a popular pick among hedge fund managers. According to Insider Monkey data, 202 hedge fund investors ...

The Danish pharma giant posted impressive data for amycretin one month after the disappointing readout of CagriSema.

Allurion catapulted nearly 200% early Friday after the company said it plans to test its weight-loss technology with an ...

Novo Nordisk A/S (NYSE:NVO) released topline results from a phase 1b/2a trial with amycretin intended for once-weekly ...

One of Novo Nordisk's next-generation obesity shots to follow up on the success of Wegovy helped patients lose 22% of their ...

Wishbone Gold said it agreed to buy Evrensel Global Natural Resources, a private company owned by Chairman Anthony Moore, in a deal classified as a reverse takeover under London Stock Exchange rules.